Fisher & Paykel Healthcare Corporation Limited (FSPKF)
USD 25.91
(0.0%)
USD 25.91
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 107.1 Million NZD | 331.85% |
| 2023 | 24.8 Million NZD | 72.22% |
| 2022 | 14.4 Million NZD | -31.75% |
| 2021 | 21.1 Million NZD | -69.46% |
| 2020 | 69.1 Million NZD | 81.36% |
| 2019 | 38.1 Million AUD | -24.55% |
| 2018 | 50.5 Million AUD | 24147.62% |
| 2017 | -210 Thousand AUD | -100.47% |
| 2016 | 44.39 Million AUD | -14.41% |
| 2015 | 51.87 Million AUD | -47.56% |
| 2014 | 98.91 Million AUD | -22.0% |
| 2013 | 126.81 Million AUD | 16.89% |
| 2012 | 108.48 Million AUD | 16.73% |
| 2011 | 92.93 Million AUD | 20.35% |
| 2010 | 77.22 Million AUD | -33.14% |
| 2009 | 115.49 Million AUD | 42.85% |
| 2008 | 80.85 Million AUD | 144.24% |
| 2007 | 33.1 Million AUD | 354.27% |
| 2006 | 7.28 Million AUD | 148.61% |
| 2005 | -14.99 Million AUD | 33.08% |
| 2004 | -22.4 Million AUD | -118.98% |
| 2003 | -10.23 Million AUD | 84.1% |
| 2002 | -64.33 Million AUD | 29.98% |
| 2001 | -91.88 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 FY | 107.1 Million NZD | 331.85% |
| 2024 Q4 | 107.1 Million NZD | 0.0% |
| 2024 Q2 | 252.9 Million NZD | 16.78% |
| 2024 Q1 | 216.56 Million NZD | 773.25% |
| 2023 Q4 | 24.8 Million NZD | 245.3% |
| 2023 FY | 24.8 Million NZD | 72.22% |
| 2023 Q1 | 75.07 Million NZD | 421.39% |
| 2023 Q2 | 97.9 Million NZD | 30.4% |
| 2023 Q3 | 7.18 Million NZD | -92.66% |
| 2022 Q4 | 14.4 Million NZD | 0.0% |
| 2022 FY | 14.4 Million NZD | -31.75% |
| 2021 Q4 | 21.1 Million NZD | 0.0% |
| 2021 FY | 21.1 Million NZD | -69.46% |
| 2020 Q4 | 69.1 Million NZD | 0.0% |
| 2020 FY | 69.1 Million NZD | 81.36% |
| 2019 Q4 | 38.1 Million AUD | 0.0% |
| 2019 FY | 38.1 Million AUD | -24.55% |
| 2018 FY | 50.5 Million AUD | 24147.62% |
| 2018 Q4 | 50.5 Million AUD | 0.0% |
| 2017 Q4 | -210 Thousand AUD | 0.0% |
| 2017 FY | -210 Thousand AUD | -100.47% |
| 2016 FY | 44.39 Million AUD | -14.41% |
| 2016 Q4 | 44.39 Million AUD | 0.0% |
| 2015 FY | 51.87 Million AUD | -47.56% |
| 2015 Q4 | 51.87 Million AUD | 0.0% |
| 2014 Q4 | 98.91 Million AUD | 0.0% |
| 2014 FY | 98.91 Million AUD | -22.0% |
| 2013 FY | 126.81 Million AUD | 16.89% |
| 2013 Q4 | 126.81 Million AUD | 0.0% |
| 2012 Q4 | 108.48 Million AUD | 0.0% |
| 2012 FY | 108.48 Million AUD | 16.73% |
| 2011 Q4 | 92.93 Million AUD | 0.0% |
| 2011 FY | 92.93 Million AUD | 20.35% |
| 2010 Q4 | 77.22 Million AUD | 0.0% |
| 2010 FY | 77.22 Million AUD | -33.14% |
| 2009 FY | 115.49 Million AUD | 42.85% |
| 2009 Q4 | 115.49 Million AUD | 0.0% |
| 2008 FY | 80.85 Million AUD | 144.24% |
| 2008 Q4 | 80.85 Million AUD | 0.0% |
| 2007 Q4 | 33.1 Million AUD | 0.0% |
| 2007 FY | 33.1 Million AUD | 354.27% |
| 2006 FY | 7.28 Million AUD | 148.61% |
| 2006 Q4 | 7.28 Million AUD | 0.0% |
| 2005 FY | -14.99 Million AUD | 33.08% |
| 2005 Q4 | -14.99 Million AUD | 0.0% |
| 2004 Q4 | -22.4 Million AUD | 0.0% |
| 2004 FY | -22.4 Million AUD | -118.98% |
| 2003 Q4 | -10.23 Million AUD | 0.0% |
| 2003 FY | -10.23 Million AUD | 84.1% |
| 2002 FY | -64.33 Million AUD | 29.98% |
| 2001 FY | -91.88 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 479.63 Thousand USD | -22229.666% |
| Ansell Limited | -54.99 Million USD | 294.738% |
| Ansell Limited | -55.1 Million USD | 294.374% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | -36.49 Million USD | 393.48% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -105.1 Thousand USD | 102001.01% |
| Psykey, Inc. | 634.59 Thousand USD | -16776.959% |
| ConvaTec Group Plc | 1.2 Billion USD | 91.079% |
| ConvaTec Group Plc | 1.2 Billion USD | 91.092% |
| Encision Inc. | 1.29 Million USD | -8197.868% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | -4538.94% |
| Innovative MedTech Inc. | 1.76 Million USD | -5968.896% |
| LifePoint, Inc. | -3.26 Million USD | 3381.229% |
| Medite Cancer Diagnostics, Inc. | 4.9 Million USD | -2083.85% |
| Paradigm Medical Industries, Inc. | 2.16 Million USD | -4853.747% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -43.3 Thousand USD | 247421.264% |
| Reflect Scientific, Inc. | -1.03 Million USD | 10444.758% |
| SmileDirectClub, Inc. | 778.67 Million USD | 86.246% |
| Sector 10, Inc. | 163 Thousand USD | -65605.521% |
| Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | 125.649% |
| SheerVision, Inc. | 57.34 Thousand USD | -186651.295% |
| United Health Products, Inc. | 660.56 Thousand USD | -16113.295% |
| Vasamed, Inc. | 22.12 Thousand USD | -484033.442% |
| Wearable Health Solutions, Inc. | 2.63 Million USD | -3970.357% |
| Yubo International Biotech Limited | 772.27 Thousand USD | -13768.045% |